Rafferty Asset Management, LLC Vertex Pharmaceuticals Inc Transaction History

Rafferty Asset Management, LLC

  • $29.7 Billion
  • Q3 2025

A detailed history of Rafferty Asset Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 81,128 shares of VRTX stock, worth $35.2 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
81,128
Previous 75,108 8.02%
Holding current value
$35.2 Million
Previous $33.4 Million 4.98%
% of portfolio
0.11%
Previous 0.11%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
BUY
$366.54 - $479.53 $2.21 Million - $2.89 Million
6,020 Added 8.02%
81,128 $31.8 Million
Q2 2025

Aug 14, 2025
BUY
$421.16 - $509.5 $1.8 Million - $2.18 Million
4,278 Added 6.04%
75,108 $33.4 Million
Q1 2025

May 14, 2025
SELL
$402.49 - $513.76 $7.8 Million - $9.96 Million
-19,389 Reduced 21.49%
70,830 $34.3 Million
Q4 2024

Feb 14, 2025
BUY
$396.64 - $516.74 $1.55 Million - $2.02 Million
3,910 Added 4.53%
90,219 $36.3 Million
Q3 2024

Nov 13, 2024
SELL
$460.0 - $505.78 $3.14 Million - $3.45 Million
-6,816 Reduced 7.32%
86,309 $40.1 Million
Q2 2024

Aug 13, 2024
BUY
$392.81 - $485.53 $5.42 Million - $6.7 Million
13,809 Added 17.41%
93,125 $43.6 Million
Q1 2024

May 13, 2024
BUY
$407.69 - $446.08 $441,935 - $483,550
1,084 Added 1.39%
79,316 $33.2 Million
Q4 2023

Feb 13, 2024
BUY
$343.0 - $410.68 $411,600 - $492,816
1,200 Added 1.56%
78,232 $31.8 Million
Q3 2023

Nov 13, 2023
BUY
$338.18 - $362.46 $2.25 Million - $2.41 Million
6,650 Added 9.45%
77,032 $26.8 Million
Q2 2023

Aug 11, 2023
BUY
$314.42 - $351.91 $1.69 Million - $1.89 Million
5,361 Added 8.25%
70,382 $24.8 Million
Q1 2023

May 11, 2023
BUY
$283.23 - $323.1 $416,064 - $474,633
1,469 Added 2.31%
65,021 $20.5 Million
Q4 2022

Feb 13, 2023
BUY
$285.76 - $321.48 $583,236 - $656,140
2,041 Added 3.32%
63,552 $18.4 Million
Q3 2022

Nov 14, 2022
BUY
$273.83 - $305.53 $4.01 Million - $4.47 Million
14,629 Added 31.2%
61,511 $17.8 Million
Q2 2022

Aug 12, 2022
SELL
$234.96 - $292.55 $2.71 Million - $3.37 Million
-11,535 Reduced 19.75%
46,882 $13.2 Million
Q1 2022

May 13, 2022
BUY
$221.42 - $260.97 $881,694 - $1.04 Million
3,982 Added 7.32%
58,417 $15.2 Million
Q4 2021

Feb 10, 2022
BUY
$177.01 - $223.45 $1.29 Million - $1.62 Million
7,270 Added 15.41%
54,435 $12 Million
Q3 2021

Nov 10, 2021
BUY
$181.39 - $202.99 $1.45 Million - $1.63 Million
8,019 Added 20.48%
47,165 $8.56 Million
Q2 2021

Aug 10, 2021
BUY
$187.49 - $221.1 $288,172 - $339,830
1,537 Added 4.09%
39,146 $7.89 Million
Q1 2021

May 10, 2021
BUY
$207.02 - $241.31 $2.61 Million - $3.04 Million
12,588 Added 50.31%
37,609 $8.08 Million
Q4 2020

Feb 10, 2021
SELL
$207.01 - $276.09 $101,641 - $135,560
-491 Reduced 1.92%
25,021 $5.91 Million
Q3 2020

Nov 13, 2020
BUY
$255.65 - $303.1 $1.1 Million - $1.3 Million
4,286 Added 20.19%
25,512 $6.94 Million
Q2 2020

Aug 07, 2020
BUY
$225.48 - $295.8 $1.27 Million - $1.66 Million
5,611 Added 35.93%
21,226 $6.16 Million
Q1 2020

May 15, 2020
SELL
$199.77 - $247.81 $4.32 Million - $5.35 Million
-21,600 Reduced 58.04%
15,615 $3.72 Million
Q4 2019

Feb 10, 2020
SELL
$166.71 - $223.91 $2.4 Million - $3.23 Million
-14,405 Reduced 27.91%
37,215 $8.15 Million
Q3 2019

Nov 14, 2019
BUY
$166.23 - $187.09 $1.64 Million - $1.85 Million
9,885 Added 23.69%
51,620 $8.75 Million
Q2 2019

Aug 09, 2019
BUY
$164.61 - $190.37 $417,944 - $483,349
2,539 Added 6.48%
41,735 $7.65 Million
Q1 2019

May 15, 2019
BUY
$163.73 - $194.7 $4.85 Million - $5.76 Million
29,602 Added 308.55%
39,196 $7.21 Million
Q4 2018

Feb 11, 2019
SELL
$151.91 - $192.21 $219,661 - $277,935
-1,446 Reduced 13.1%
9,594 $1.59 Million
Q3 2018

Nov 09, 2018
BUY
$167.73 - $192.74 $7,883 - $9,058
47 Added 0.43%
11,040 $2.13 Million
Q2 2018

Aug 14, 2018
BUY
$145.72 - $169.96 $256,321 - $298,959
1,759 Added 19.05%
10,993 $1.87 Million
Q1 2018

May 15, 2018
SELL
$151.6 - $177.13 $130,830 - $152,863
-863 Reduced 8.55%
9,234 $1.51 Million
Q4 2017

Feb 14, 2018
SELL
$137.28 - $155.55 $672,809 - $762,350
-4,901 Reduced 32.68%
10,097 $1.51 Million
Q3 2017

Nov 13, 2017
BUY
$148.13 - $162.24 $2.22 Million - $2.43 Million
14,998
14,998 $2.28 Million

Others Institutions Holding VRTX

# of Institutions
1,786
Shares Held
231M
Call Options Held
1.83M
Put Options Held
1.21M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $111B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email